Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Dine

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Soins. Pediatrie, Puericulture|September 1, 1996
[Maturity and critical situations]L Dine
Journal of Cultural Diversity|February 1, 2012
Nursing education on lymphedema self-management and self-monitoring in a South African oncology clinicJennifer L Dine, Melanie K Schneider Austin, Jane M Armer
Cells|December 11, 2022
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer TherapyManjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, et al.
Breast Cancer Research : BCR|April 22, 2014
Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screeningSireesha V Garimella, Kristie Gehlhaus, Jennifer L Dine, et al.
Breast Cancer Research and Treatment|January 14, 2016
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and AxlJennifer L Dine, Ciara C O'Sullivan, Donna Voeller, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Soins. Pediatrie, Puericulture|September 1, 1996
[Maturity and critical situations]L Dine
Journal of Cultural Diversity|February 1, 2012
Nursing education on lymphedema self-management and self-monitoring in a South African oncology clinicJennifer L Dine, Melanie K Schneider Austin, Jane M Armer
Cells|December 11, 2022
Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer TherapyManjari Kundu, Yoshimi Endo Greer, Jennifer L Dine, et al.
Breast Cancer Research : BCR|April 22, 2014
Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screeningSireesha V Garimella, Kristie Gehlhaus, Jennifer L Dine, et al.
Breast Cancer Research and Treatment|January 14, 2016
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and AxlJennifer L Dine, Ciara C O'Sullivan, Donna Voeller, et al.
Pageof 1